Effect of S100A12 and soluble receptor for advanced glycation end products on the occurrence of severe acute pancreatitis

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-2980|17|7|475-482

ISSN： 1751-2972

Source： Journal of Digestive Diseases, Vol.17, Iss.7, 2016-07, pp. : 475-482

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Kinetics, Role and Therapeutic Implications of Endogenous Soluble form of Receptor for Advanced Glycation end Products (sRAGE) in Diabetes

By  

Current Drug Targets, Vol. 8, Iss. 10, 2007-10 ,pp. : 1138-1143

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating Soluble Receptor for Advanced Glycation End Products is Inversely Correlated to Oxidized Low-density Lipoproteins in Asymptomatic Subjects

By Kotani K   Caccavello R   Taniguchi N   Gugliucci A  

The Journal of International Medical Research, Vol. 40, Iss. 5, 2012-09 ,pp. : 1878-1883

Field House Publishing

Access to resources Recommend Favorite

Soluble Receptor for Advanced Glycation End Products: From Disease Marker to Potential Therapeutic Target

By  

Current Medicinal Chemistry, Vol. 13, Iss. 17, 2006-07 ,pp. : 1971-1978

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation End Products (AGEs) and their Receptor (RAGE) System in Diabetic Retinopathy

By  

Current Drug Discovery Technologies, Vol. 3, Iss. 1, 2006-03 ,pp. : 83-88

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System

By  

Current Pharmaceutical Design, Vol. 23, Iss. 8, 2017-04 ,pp. : 1135-1141

Bentham Science Publishers

Access to resources Recommend Favorite